WBB Securities Sponsors BioCentury’s 20th Annual NewsMakers Conference
Posted: Oct 1st, 2013In: Press ReleasesExecutive Teams of Emerging Biotech Companies to Present to Investor Community
Read More about WBB Securities Sponsors BioCentury’s 20th Annual NewsMakers ConferenceFinancial Times and Thomson Reuters name Steve Brozak as a 2013 StarMine
Posted: Aug 22nd, 2013In: Press ReleasesWBB's Steve Brozak named "Top Stock Picker" in Pharmaceuticals
Read More about Financial Times and Thomson Reuters name Steve Brozak as a 2013 StarMineWBB Securities Retained as Financial Advisor to Navidea Biopharmaceuticals, Inc.
Posted: Jun 26th, 2013In: Press ReleasesNavidea closes $25 million debt financing with GE Capital to finance and manage commercialization of approved radiopharmaceutical
Read More about WBB Securities Retained as Financial Advisor to Navidea Biopharmaceuticals, Inc.WBB Securities Retained as Financial Advisor to Cempra, Inc.
Posted: Jun 19th, 2013In: Press ReleasesCempra closes $54.2 million financing to support its efforts to develop and commercialize novel antibiotic treatments
Read More about WBB Securities Retained as Financial Advisor to Cempra, Inc.WBB Sponsors 2013 BIO CEO
Posted: Feb 1st, 2013In: Press ReleasesConference is focused on established and emerging publicly traded and select private biotech companies
Read More about WBB Sponsors 2013 BIO CEOWBB Securities’ Steve Brozak Speaks on Drug Development Costs at Bloomberg Healthcare Innovations Conference
Posted: Oct 2nd, 2012In: Press ReleasesBloomberg Healthcare Conference aims to identify promising innovations in the healthcare space
Read More about WBB Securities’ Steve Brozak Speaks on Drug Development Costs at Bloomberg Healthcare Innovations ConferenceWBB Securities Sponsors 19th Annual NewsMakers in the Biotech Industry Conference
Posted: Sep 4th, 2012In: Press ReleasesExecutive Teams of Emerging Biotech Companies to Present to Investor Community
Read More about WBB Securities Sponsors 19th Annual NewsMakers in the Biotech Industry ConferenceWBB Securities’ Brozak to Co-Present at 2012 Biodefense Vaccines and Therapeutics Summit
Posted: Jun 6th, 2012In: Press ReleasesSummit will provide progress of various countermeasures from the Public Health Emergency Medical Countermeasures Enterprise Review and how they will impact biodefense
Read More about WBB Securities’ Brozak to Co-Present at 2012 Biodefense Vaccines and Therapeutics SummitAthersys Retains WBB Securities as Financial Advisor
Posted: Mar 15th, 2012In: Press ReleasesWBB Securities, LLC has been retained by Athersys, Inc.
Read More about Athersys Retains WBB Securities as Financial AdvisorWBB Securities’ Stephen Brozak to Moderate Panel at 2012 BIO CEO and Investor Conference
Posted: Feb 11th, 2012In: Press ReleasesMr. Brozak to be joined by distinguished panel of venture investors and leading diagnostic companies
Read More about WBB Securities’ Stephen Brozak to Moderate Panel at 2012 BIO CEO and Investor Conference